OmniAb, Inc. (OABI)
2.15
-0.01
(-0.46%)
USD |
NASDAQ |
Dec 12, 16:00
2.155
0.00 (0.00%)
After-Hours: 20:00
OmniAb EPS Diluted (Quarterly): -0.144 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.875 |
| GT Biopharma, Inc. | -0.8268 |
| Karyopharm Therapeutics, Inc. | -3.821 |
| Zevra Therapeutics, Inc. | -0.0097 |
| Foghorn Therapeutics, Inc. | -0.2514 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.52M |
| Revenue (Quarterly) | 2.239M |
| Total Expenses (Quarterly) | 18.76M |
| Enterprise Value | 271.07M |
| Gross Profit Margin (Quarterly) | -109.2% |
| Profit Margin (Quarterly) | -738.1% |
| Earnings Yield | -27.47% |
| Normalized Earnings Yield | -27.13 |